Joseph Haas

Type: Person
Name: Joseph Haas
First reported Aug 15 2014 - Updated Aug 15 2014 - 2 reports

Haas sentenced in arson that hurt firefighters

MARTIN COUNTY, Fla. - A judge has sentenced Joseph Haas to 65 years in prison for deliberately setting a fire that ended up injuring four Martin County firefighters.Haas was found guilty in a trial in July of arson, arson resulting in serious injury, ... [Published WPTV TV Channel 5 - Aug 15 2014]

Quotes

"i heard it on that recording. yes, sir. i heard it on that recording and i don't remember saying it because i was not in my right state of mind" said Haas

More Content

All (7) | News (2) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Haas sentenced in arson that hurt firefighters [Published WPTV TV Channel 5 - Aug 15 2014]
Man accused of setting house fire and injuring ... [Published WPBF - Aug 15 2014]
What Is the Buoyant Biotech IPO Scene Doing to ... [Published The IN VIVO Blog - Mar 07 2014]
DOTW Keeps Tabs As Tax Trimming Fuels Deals [Published The IN VIVO Blog - Feb 28 2014]
Financings of the Fortnight And the Neverending... [Published The IN VIVO Blog - Feb 21 2014]
Deals Of The Week: UCSF Catalyzes R&D Tech-Tran... [Published The IN VIVO Blog - Feb 14 2014]
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
What Is the Buoyant Biotech IPO Scene Doing to ... [Published The IN VIVO Blog - Mar 07 2014]
Despite a slight slowdown, there's considerable cash already sloshing around the biotech IPO space. There's (still!) plenty more stacked up in investor suitcases from California to the New York Island just waiting to back anything with a pulse. The ...
DOTW Keeps Tabs As Tax Trimming Fuels Deals [Published The IN VIVO Blog - Feb 28 2014]
As an industry, biopharma actually fares pretty well when it comes to taxes. Among profitable companies, biotech and pharma have some of the lowest effective U.S. tax rates compared to companies in other sectors. But that doesn’t mean they have stopped ...
Financings of the Fortnight And the Neverending... [Published The IN VIVO Blog - Feb 21 2014]
Somewhere out there, perhaps, is the end of NovImmune's Series B round.More than a year ago, our friends at START-UP examined the fates of biotechs that had reeled in huge private financing rounds. Giant biotech venture rounds are back with a buzz ...
Deals Of The Week: UCSF Catalyzes R&D Tech-Tran... [Published The IN VIVO Blog - Feb 14 2014]
Neither MedImmune, the biologics arm of AstraZeneca, or the University of California, San Francisco, is a stranger to R&D collaboration between private industry and academia, but the agreement they signed on Feb. 11 is somewhat unique in that it ...
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
Merck & Co. Inc.’s Feb. 5 announcement that it is collaborating with three companies to test various combinations of its investigational oncology compound MK-3475 with their drugs highlights the extent to which the big pharma is committed to building ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.